Nephrocare Health Services Limited (NSE:NEPHROPLUS)
India · Delayed Price · Currency is INR 607.50
+22.05 (3.77%)
At close: May 22, 2026
Nephrocare Health Services Earnings Call Transcripts
Fiscal Year 2026
-
FY 2026 saw 32% revenue growth and 75% adjusted PAT growth, driven by international expansion, higher treatment volumes, and improved margins. The network now spans 524 clinics across five countries, with strong cash flow and disciplined capital allocation supporting continued growth.
-
Revenue grew 32% YoY in Q3 and 37% for nine months FY 2026, with international business now 41% of revenue. Adjusted EBITDA margin rose to 24.3%, and ROCE is projected to reach 24.7%. Guidance is for 15%-20% revenue CAGR over 3-4 years.